Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MRK:NYQ since
announced
Transaction
value
Caraway Therapeutics IncAnnounced21 Nov 202321 Nov 2023Announced27.57%610.00m
Data delayed at least 15 minutes, as of May 20 2024 21:10 BST.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Caixa DTVM SAas of 31 Jan 2024308.93k0.00%
BB Gest�o de Recursos DTVM SAas of 31 Jan 2024178.50k0.00%
Safra Asset Management Ltda.as of 31 Jan 202466.30k0.00%
Bram Bradesco Asset Management S/A DTVMas of 31 Jan 202441.92k0.00%
XP Allocation Asset Management Ltda.as of 31 Jan 20242.58k0.00%
More ▼
Data from 31 Jan 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.